U.S. stocks traded with a cautious, slightly risk‑off tone on Monday, July 13, 2026, as investors weighed Middle East tensions, upcoming earnings, and the next batch of inflation data, while select healthcare, industrial, and media names saw idiosyncratic moves.
Market overview – indices, sectors, flows
U.S. Major indices closed lower at the end of the day, including the Dow Jones Industrial Average at 52,498.64, -.26% , S&P 500 at 7,515.34, -.79%, and Nasdaq Composite at 25,873.18, -1.55%, with large‑cap tech tempering gains in cyclicals and energy. Risk sentiment was constrained by renewed geopolitical stress, with Iran‑related headlines driving a modest bid into traditional havens and out of higher‑beta areas. European markets were described as “mixed,” with tech softness offset by select value and commodity‑linked strength, while Asia finished mostly lower on the Iran‑driven risk‑off tone. This backdrop kept intraday breadth in the U.S. choppy, as traders used strength to lighten exposure ahead of earnings season. The small caps on the Russell 200 closed at 2,953.17, -.93% and up +18.99% YTD.
Macroeconomic and policy backdrop
The macro narrative remains dominated by the interplay between inflation expectations, the Federal Reserve’s reaction function, and oil‑linked geopolitical risks. Weekly economic commentary pointed to an environment where growth is moderating but still positive, leaving the Fed balancing progress on inflation against the risk of tightening into slowing activity. With new CPI and PPI readings on deck, U.S. markets are focused on whether disinflation remains intact enough to support the current path of policy rates. At the same time, Iran‑related strikes and tensions around energy transit routes have re‑introduced tail‑risk scenarios for oil prices which jumped to $78.29, +9.83% on Monday which could complicate the inflation trajectory if sustained. Global macro strategists highlighted that while the base case still favors a contained conflict, even short‑term disruptions could ripple into risk assets and raise term premiums across rates markets.
Geopolitics – Trump, Iran, and the Strait of Hormuz
The White House remains a focal point, with President Donald Trump’s administration signaling a harder line on Iran’s behavior in and around the Strait of Hormuz, including discussions around imposing charges or reimbursement measures tied to security and transit protection. Such rhetoric raises the perceived risk premium on shipping through this critical chokepoint, which handles a significant share of global seaborne crude, and traders are monitoring for any concrete policy steps that could affect freight and energy markets. Market quick‑take commentary framed Iran‑related strikes as a key catalyst for Monday’s risk‑off impulses in Asia and selective de‑risking in global equities. For equity investors, the immediate read‑through is twofold: higher potential volatility in energy and shipping, and a possible knock‑on impact on inflation prints, which feeds directly into Fed expectations and equity valuations.
Housing, commodities, and cross‑asset context
Outside equities, housing market updates for July 13, 2026, emphasize a still‑constrained inventory backdrop and gradually cooling price growth, with buyers facing a complex mix of higher cumulative mortgage costs and modestly improving affordability as rates stabilize. This housing dynamic feeds into broader macro expectations around consumer spending, construction activity, and regional economic resilience.
Commodity commentary points to ongoing volatility in certain contracts, with traders responding to weekend developments and adjusting positioning in line with perceived geopolitical risk and physical demand requirements. Gold‑backed ETFs continue to attract attention as investors weigh strategic hedges against macro and geopolitical uncertainty, reflecting steady, positive flows in the first half of the year. Gold closed around $4,007.20/oz. and Silver closed at $57.91/oz.
VP Watchlist Updates
Amwell® (NYSE: AMWL)
Amwell® (NYSE: AMWL) a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, closed at $11.01 +11.10% and up 124.24% YTD.
Eupraxia Pharmaceuticals Inc. (EPRX)
Eupraxia Pharmaceuticals Inc. (EPRX, $6.43) a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, announced (July 7) the appointment of Robert Bazemore, Amy Pottand Dr Helen Thackray to the Board of Directors. “We are delighted for Robert, Amy and Helen to join our Board of Directors at a pivotal stage for the company.” said Dr. James A. Helliwell, Chief Executive Officer of Eupraxia. “Their collective expertise across late-stage drug development, commercial strategy, and global product launches will be invaluable as we execute on several key upcoming milestones for EP-104GI and continue to expand our pipeline. Their appointments reflect the commitment of Eupraxia to advancing and expanding our gastroenterology assets in an efficient and effective manner. I also want to thank Paul Geyer and Michael Wilmink for all of the support and contributions they have made to Eupraxia over the last decade as we proved the function and potential of the Diffusphere technology.”
Eupraxia announced (May 5) the first Eosinophilic Esophagitis Endoscopic Reference Score (EREFS) data from its ongoing Phase 1b/2a part of the RESOLVE trial evaluating EP-104GI for the treatment of eosinophilic esophagitis (“EoE”). These data were also presented at the ongoing Digestive Disease Week (“DDW”) conference in Chicago. “The EREFS is an important, validated visual index of severity of EoE disease in the esophagus of patients. It measures edema, rings and strictures and other visible markers of disease often associated with symptoms. Today’s data demonstrated improvement in two key outcomes with EP-104GI in the treatment of EoE: first, that a full injection protocol of 20 injections resulted in more pronounced improvement than a protocol with fewer injections and less coverage area within the esophagus; second, with the higher number of injections, a consistent response in both the inflammatory and fibrotic sub scores of EREFS was observed,” said Dr. James A. Helliwell, Chief Executive Officer of Eupraxia. “This EREFS data being reported at DDW is consistent with the improvements we have seen in EoE symptoms and tissue health (EoEHSS) and suggests improvement in inflammation, fibrosis and the associated narrowing of the esophagus.”
Modular Medical, Inc. (NASDAQ: MODD)
Modular Medical, Inc. (NASDAQ: MODD, $3.99), a leader in innovative, patient-centric insulin delivery, today (June 30) announced that the first patients have completed onboarding and training and are now actively using the Pivot™ tubeless insulin patch pump in real-world settings. This milestone marks the transition of the Pivot pump from development into active patient use and represents a significant step in Modular Medical’s commercialization strategy. The Company will now begin collecting real world utilization data and user feedback to support broader adoption and continued product deployment optimization.
MODD announced ( June 26) that the Pivot™ tubeless insulin patch pump is now shipping to physician offices for training. Upon completion of training, these pumps will be presented to potential patients in the next few days and weeks. The Company intends to expand the roster of practices that offer Pivot over the coming months. This is another significant milestone in the deployment of Pivot. Modular Medical looks forward to updating the market when these first patients are using the pump to deliver insulin. The Pivot pump is purpose-built for adults with diabetes on daily injections who have faced cost, complexity, and usability barriers with traditional pump systems. This group represents an estimated 70% of insulin-dependent adults who remain on multiple daily injections, a multi-billion-dollar opportunity within the diabetes technology market.
MODD announced (June 24) that the Pivot™ tubeless insulin patch pump is now commercially available. This marks the start of real-world patient use, and the Company’s transition to a commercial-stage medical device company. As only the second fully electronic, tubeless insulin pump available in the United States, Pivot is designed to make pump therapy simpler to learn and easier to live with. Its removable two-part design and 3 mL reservoir, intuitive interface, and flexible, wearable form factor support everyday activities, such as showering and sports, with no battery recharging required – all while maintaining clinical accuracy and connectivity. “Reaching commercial availability is a transformational milestone that marks Modular Medical’s transition from a development-stage company to a revenue-generating commercial business,” said Jeb Besser, Chief Executive Officer of Modular Medical. “As only the second fully electronic tubeless pump on the U.S. market, Pivot is positioned to serve a large, underserved ‘almost-pumper’ population. With first shipments beginning this week, we are focused on disciplined execution, as we scale adoption and seek to build long-term value for patients and shareholders.”
On (June 4) the launch of PivotPump.com, a patient-focused website designed to support individuals seeking a simpler path to insulin pump therapy. This launch follows the Company’s receipt of U.S. Food and Drug Administration (“FDA”) clearance in April 2026 for its Pivot™ insulin delivery system. The FDA clearance represents a significant milestone in Modular Medical’s strategy to expand access to insulin pump technology, particularly among individuals historically underserved by existing solutions. The Company remains on track for commercial launch in the fall of 2026. Pivot is designed for people living with diabetes who rely on daily insulin injections, as well as those who have encountered technological, usability, or cost-related barriers with traditional pump systems. The system emphasizes simplicity and ease of use for the patient and full access to clinical information for the clinician to reduce adoption friction. The PivotPump.com website provides accessible, educational content on insulin pump therapy and highlights the Company’s focus on real-world usability and supporting patients in evaluating and adopting pump-based diabetes care.
Similarweb Ltd. (NYSE: SMWB)
Similarweb Ltd. (NYSE: SMWB, $7.13, +7.06%), a leading digital data and analytics company powering critical business decisions, announced (June 15) that it has surpassed $300 million in Annual Recurring Revenue (ARR)act 5-days and signed two multi-year enterprise contracts, each representing seven-figure ARR commitments. Collectively, these contracts represent approximately $47 million in Total Contract Value to be recognized over the next three years and were signed during the second quarter of 2026.
NVIDIA (NVDA)
NVIDIA (NVDA) closes at $203.53.
The InterGroup Corporation (NASDAQ: INTG)
The InterGroup Corporation (NASDAQ: INTG), a diversified holding company with interests in hospitality, real estate, and marketable securities. InterGroup consolidates its majority‑owned subsidiary Portsmouth Square, Inc., which owns the Hilton San Francisco Financial District hotel and related facilities, closed at $42.60, +7.49%
Agenus (AGEN) – oversubscribed private placement
In healthcare, immuno‑oncology player Agenus Inc. (AGEN, $6.12, +82.69%) announced an oversubscribed private placement, a move that signals continued investor interest in its pipeline and platform despite broader market volatility. According to regulatory filings, the company entered into a securities purchase agreement for a financing transaction expected to close mid‑July 2026, bolstering its balance sheet and providing incremental runway for clinical development. For biotech‑focused investors, the transaction underscores a still‑functional capital markets environment for differentiated oncology stories, even as generalist risk appetite fluctuates with macro headlines. The oversubscription dynamic may also support the narrative of specialist demand for late‑stage and platform‑driven biotech names, a theme to watch as more companies tap private and structured financing this quarter.
Twin Vee PowerCats Co. (VEEE) – corporate actions
In industrials and consumer‑adjacent names, Twin Vee PowerCats Co. (VEEE, $24.86, +415.77%) has remained active on the corporate actions front, with a series of moves aimed at strengthening its capital markets profile and improving long‑term flexibility. Recent disclosures highlight actions such as reverse stock splits to regain compliance with Nasdaq’s bid‑price requirements and a reincorporation to Nevada designed to enhance corporate flexibility and reduce costs over time. These steps reflect the broader trend of small‑cap and micro‑cap companies optimizing their corporate structure, listings, and capital access in response to tighter liquidity conditions and higher volatility. For investors, the Twin Vee story illustrates how tactical governance and listing decisions can be used to preserve market access while management pursues operational growth in niche recreational marine segments. Today, Twin Vee, a manufacturer, distributor and marketer of power sport boats, announced that it has entered into a definitive agreement for a transformative transaction that will combine a merger involving the publicly traded company with the concurrent privatization of its boating business under the brands Twin Vee and Bahama Boat Works.
Disney and streaming – structural media shifts
Media remains in flux, with fresh commentary around The Walt Disney Company (DIS, $96, .40%) and the strategically sensitive question of legacy media’s long‑term role in streaming. Discussion of Disney potentially exiting or reshaping its direct‑to‑consumer streaming footprint has fueled debate about whether such a move could catalyze industry consolidation or re‑pricing across the streaming and content landscape. Analysts note that any significant pivot by Disney in streaming would have implications not only for DIS shareholders but also for peers like Netflix (NFLX, $73.93, +.63%), Warner Bros. Discovery (WBD, $27.09, +1.88%), and Comcast’s NBCUniversal (CMCSA, $23.97, +1.70%), which are all navigating profitability, subscriber saturation, and evolving distribution economics.
The Sources
- Yahoo Finance – “Stock market today: Monday, July 13 – Dow, S&P 500, Nasdaq live updates”
https://finance.yahoo.com/markets/live/stock-market-today-monday-july-13-dow-sp-nasdaq-113249278.html - CNBC – “Stock market today: Live updates – July 12–13, 2026”
https://www.cnbc.com/2026/07/12/stock-market-today-live-updates.html - CNBC – “Trump says Iran should reimburse charges related to security in the Strait of Hormuz” (July 13, 2026)
https://www.cnbc.com/2026/07/13/trump-iran-hormuz-strait-charge-reimburse.html - Yahoo Finance – Healthcare: “Agenus announces oversubscribed private placement”
https://finance.yahoo.com/healthcare/articles/agenus-announces-oversubscribed-private-placement-100000154.html - SEC filing (StockTitan) – “[8-K] AGENUS INC reports material event”
https://www.stocktitan.net/sec-filings/AGEN/8-k-agenus-inc-reports-material-event-89d64bcf5da8.html - Twin Vee PowerCats Co. – Investor relations press releases
https://ir.twinvee.com/news-events/press-releases - Yahoo Finance – “Twin Vee PowerCats Co. announces corporate actions”
https://finance.yahoo.com/markets/stocks/articles/twin-vee-powercats-co-announces-123000071.html - Yahoo Finance – Media & Advertising: “Disney exiting streaming could spur industry shift”
https://finance.yahoo.com/media-advertising/articles/disney-exiting-streaming-could-spur-122433164.html - BlackRock Investment Institute – Weekly market commentary
https://www.blackrock.com/us/individual/insights/blackrock-investment-institute/weekly-commentary - Westpac IQ – Weekly Economic Commentary, July 13, 2026
https://www.westpaciq.com.au/economics/2026/07/weekly-economic-commentary-13-jul-2026 - Saxo – “Market Quick Take: Iran strikes rattle markets – 13 July 2026”
https://www.home.saxo/content/articles/macro/market-quick-take—iran-strikes-rattle-markets—13-july-2026-13072026 - Realtor.com – “Economic and Housing Market Outlook – July 13, 2026”
https://www.realtor.com/research/video-economic-and-housing-market-update-july-13-2026/ - Czapp – “Daily Market Price Updates and Commentary – 13th July 2026”
https://www.czapp.com/analyst-insights/daily-market-price-updates-and-commentary-13th-july-2026/ - World Gold Council – “Global gold‑backed ETF holdings and flows”
https://www.gold.org/goldhub/data/global-gold-backed-etf-holdings-and-flows - Edward Jones – Daily market snapshot
https://www.edwardjones.com/us-en/market-news-insights/stock-market-news/daily-market-recap
Stay Updated with Vista Partners
Subscribe to receive market insights, investing ideas, and the latest updates directly in your inbox.
